chr1-183023897-G-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_002293.4(LAMC1):āc.181G>Cā(p.Val61Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00008 in 1,612,890 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_002293.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LAMC1 | NM_002293.4 | c.181G>C | p.Val61Leu | missense_variant | 1/28 | ENST00000258341.5 | NP_002284.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LAMC1 | ENST00000258341.5 | c.181G>C | p.Val61Leu | missense_variant | 1/28 | 1 | NM_002293.4 | ENSP00000258341 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152164Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.0000243 AC: 6AN: 247034Hom.: 0 AF XY: 0.00000744 AC XY: 1AN XY: 134386
GnomAD4 exome AF: 0.0000849 AC: 124AN: 1460726Hom.: 0 Cov.: 34 AF XY: 0.0000867 AC XY: 63AN XY: 726670
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152164Hom.: 1 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74328
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 07, 2021 | The c.181G>C (p.V61L) alteration is located in exon 1 (coding exon 1) of the LAMC1 gene. This alteration results from a G to C substitution at nucleotide position 181, causing the valine (V) at amino acid position 61 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at